Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
Published Online: 2022-06-?
Journal: The Lancet Gastroenterology & Hepatology•Publisher: Elsevier BV
Authors: Ah-Rong Nam•Dae-Won Lee•Do-Youn Oh•Jae-Min Kim•Jeesun Yoon•Jin Won Kim•Ju-Hee Bang•Kyoung-Seok Oh•Kyung-Hun Lee•Marlon C Rebelatto•Patricia McCoon•Qu Zhang•Song Wu•Tae-Yong Kim•Violeta Guthrie•Weimin Li•Young Lee
